These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 2137934

  • 21. Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation.
    Mumcuoglu M, Weiss L, Spivak J, Slavin S.
    Bone Marrow Transplant; 1989 Mar; 4(2):143-6. PubMed ID: 2650782
    [Abstract] [Full Text] [Related]

  • 22. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
    Slaper-Cortenbach IC, Admiraal LG, van Leeuwen EF, Kerr JM, von dem Borne AE, Tetteroo PA.
    Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
    [Abstract] [Full Text] [Related]

  • 23. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J, Fehér I, Kovács P.
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [Abstract] [Full Text] [Related]

  • 24. Elimination of clonogenic tumor cells from HL-60, Daudi, and U-937 cell lines by laser photoradiation therapy: implications for autologous bone marrow purging.
    Gulliya KS, Pervaiz S.
    Blood; 1989 Mar; 73(4):1059-65. PubMed ID: 2920207
    [Abstract] [Full Text] [Related]

  • 25. Dye-mediated photosensitization of murine neuroblastoma cells.
    Sieber F, Sieber-Blum M.
    Cancer Res; 1986 Apr; 46(4 Pt 2):2072-6. PubMed ID: 3512078
    [Abstract] [Full Text] [Related]

  • 26. Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cells.
    Lagneaux L, Marie JP, Delforge A, Socquet M, Thevenin D, Zittoun R, Stryckmans P.
    Exp Hematol; 1989 Aug; 17(7):843-6. PubMed ID: 2753092
    [Abstract] [Full Text] [Related]

  • 27. Merocyanine 540 mediated photolysis of normal bone marrow, committed hemopoietic progenitors and neoplastic cells. implications for bone marrow purging.
    Lydaki E, Dimitriou H, Papazoglou T, Liu WQ, Kalmanti M.
    Leuk Res; 1997 Jul; 21(7):641-50. PubMed ID: 9301685
    [Abstract] [Full Text] [Related]

  • 28. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
    Peters RH, Brandon CS, Avila LA, Gale GR, Stuart RK.
    Prog Clin Biol Res; 1990 Jul; 333():57-68. PubMed ID: 2309001
    [Abstract] [Full Text] [Related]

  • 29. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE, Benninger L, Cooper S, Hague N, Benjamin RS, Vadhan-Raj S.
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [Abstract] [Full Text] [Related]

  • 30. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells.
    Dietzfelbinger HF, Lang A, Oberberg D, Rastetter JW, Berdel WE.
    Exp Hematol; 1992 Feb; 20(2):178-83. PubMed ID: 1544386
    [Abstract] [Full Text] [Related]

  • 31. Elimination of leukemic cells by laser photodynamic therapy.
    Gulliya KS, Fay JW, Dowben RM, Berkholder S, Matthews JL.
    Cancer Chemother Pharmacol; 1988 Feb; 22(3):211-4. PubMed ID: 3165726
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of doxorubicin in combination with mafosfamide for in vitro elimination of myeloid and lymphoid tumor cells from human bone marrow.
    Domenech J, Georget MT, Gihana E, Colombat P, Brémond JL, Chassaigne M, Lamagnère JP, Binet C.
    Bone Marrow Transplant; 1992 Feb; 9(2):101-6. PubMed ID: 1571708
    [Abstract] [Full Text] [Related]

  • 33. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 34. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
    Slavin S, Mumcuoglu M, Landesberg-Weisz A, Kedar E.
    Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
    [Abstract] [Full Text] [Related]

  • 35. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 36. A comparison of the abilities of nitrobenzylthioinosine, dilazep, and dipyridamole to protect human hematopoietic cells from 7-deazaadenosine (tubercidin).
    Cass CE, King KM, Montaño JT, Janowska-Wieczorek A.
    Cancer Res; 1992 Nov 01; 52(21):5879-86. PubMed ID: 1394215
    [Abstract] [Full Text] [Related]

  • 37. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D, Shi ZH, Campos L, Rabat M, Bonnier S, Poncelet P, Laurent JC, Fiere D.
    Bone Marrow Transplant; 1990 Dec 01; 6(6):385-90. PubMed ID: 1982926
    [Abstract] [Full Text] [Related]

  • 38. [Selective photodynamic destruction of leukemic cells].
    Hrkal Z, Cajthamlová H, Grebenová D, Bartosová J, Klamová H, Marinov J.
    Cas Lek Cesk; 2000 Mar 15; 139(5):148-54. PubMed ID: 10838736
    [Abstract] [Full Text] [Related]

  • 39. Normal and malignant human myeloid progenitors differ in their sensitivity to hyperthermia.
    Murphy PB, Richman CM.
    Exp Hematol; 1989 Dec 15; 17(11):1105-9. PubMed ID: 2583254
    [Abstract] [Full Text] [Related]

  • 40. Photochemical purging of autologous bone marrow grafts: assessment of damage to stem cells and the microenvironment in long-term marrow cultures.
    Kubo Y, Sieber F.
    Bone Marrow Transplant; 1997 Jul 15; 20(1):27-31. PubMed ID: 9232252
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.